Bayview Legacy, an Arteris insider, sold 100,000 shares at $20.75 per share on September 1, 2026. The transaction leaves Bayview Legacy owning 8,229,071 Arteris shares, giving investors the reported post-sale ownership figure for the insider.
Key Highlights
- Bayview Legacy is identified as an insider of Arteris, Inc.
- Bayview Legacy sold 100,000 Arteris shares in the reported insider transaction.
- Bayview Legacy owned 8,229,071 Arteris shares after completing the sale.
Arteris, Inc. (NASDAQ: AIP) saw insider Bayview Legacy, LLC sell 100,000 shares at $20.75 per share on September 1, 2026. The transaction involved Arteris common stock and left Bayview Legacy with 8,229,071 shares afterward.
Bayview Legacy Sale Priced at $20.75 Per Share
Bayview Legacy completed the sale at a price of $20.75 per share. The transaction covered 100,000 Arteris shares. The sale was recorded on September 1, 2026.
Post-Sale Ownership Stands at 8,229,071 Shares
That post-transaction figure is the ownership position associated with the insider following the sale. The reported transaction therefore includes both the sale price of $20.75 per share and the remaining shareholding of 8,229,071 shares.
FAQs
Q: How many Arteris shares did Bayview Legacy sell?
A: Bayview Legacy sold 100,000 Arteris shares in the reported insider transaction. The shares were sold at $20.75 per share on September 1, 2026.
Q: How many Arteris shares does Bayview Legacy own after the sale?
A: Bayview Legacy owned 8,229,071 Arteris shares after completing the sale. This figure represents its reported post-transaction ownership position following the September 1, 2026 transaction.
Q: What was the Arteris insider transaction price?
A: The Arteris insider transaction was priced at $20.75 per share. Bayview Legacy sold 100,000 shares at that price on September 1, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.